Quest Diagnostics Inc
DGX
Company Profile
Business description
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Contact
500 Plaza Drive
SecaucusNJ07094
USAT: +1 973 520-2700
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
56,000
Stocks News & Analysis
stocks
A top global stock to buy after a big change in its forecast
Undervalued by 24%, this wide-moat stock is a buy now.
stocks
Does the AI trade still have room to run?
Where Morningstar analysts see opportunities—and where they don’t.
stocks
More gas left in the tank for ASX highflyer
Shares jumped after results and are screening as overvalued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,189.90 | 15.70 | 0.17% |
| CAC 40 | 8,131.15 | 11.90 | -0.15% |
| DAX 40 | 24,933.08 | 32.37 | 0.13% |
| Dow JONES (US) | 49,412.40 | 313.69 | 0.64% |
| FTSE 100 | 10,148.85 | 5.41 | 0.05% |
| HKSE | 26,765.52 | 135.56 | 0.51% |
| NASDAQ | 23,601.36 | 100.11 | 0.43% |
| Nikkei 225 | 52,885.25 | 803.64 | -1.50% |
| NZX 50 Index | 13,423.39 | 37.35 | -0.28% |
| S&P 500 | 6,950.23 | 34.62 | 0.50% |
| S&P/ASX 200 | 8,860.10 | 15.00 | 0.17% |
| SSE Composite Index | 4,132.60 | 3.56 | -0.09% |